SCHEMBL20109247

SCHEMBL20109247

C=C(C(Cc1ccc(C)cc1)C(=O)OCC)P1(=N)N(c2ccccc2)CCN1c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MMP8 P22894 1/20 0.44
ALDH1A1 P00352 4/20 0.40
TP53 P04637 1/20 0.40
NPY1R P25929 1/20 0.38
NPY2R P49146 1/20 0.38
MAPT P10636 1/20 0.36
PKM P14618 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
HCRTR2 O43614 1/20 0.35
TDP1 Q9NUW8 1/20 0.34
GABRA2 P47869 1/20 0.34
GABRB2 P47870 1/20 0.34
ATM Q13315 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CYP1A2 P05177 1/20 0.34
POLB P06746 1/20 0.34
CYP2C9 P11712 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20113547 0.95 MMP8 (0.49) MMP8ALDH1A1TP53NPY1RNPY2R
SCHEMBL20113465 0.92 MMP8 (0.42) MMP8ALDH1A1TP53NPY1RNPY2R
SCHEMBL20113457 0.89 MMP8 (0.40) MMP8ALDH1A1TP53NPY1RNPY2R
SCHEMBL20109149 0.88 MMP8 (0.44) MMP8ALDH1A1TP53NPY1RNPY2R
SCHEMBL20109223 0.87 MMP8 (0.44) MMP8ALDH1A1TP53NPY1RNPY2R
SCHEMBL20113634 0.86 MMP8 (0.38) MMP8ALDH1A1TP53MAPTMEN1
SCHEMBL20109245 0.85 MMP8 (0.36) MMP8ALDH1A1TP53MAPTTDP1
SCHEMBL20113631 0.84 ALDH1A1 (0.43) MMP8ALDH1A1MAPTMEN1KMT2A
SCHEMBL20113534 0.83 OPRD1 (0.36) MMP8ALDH1A1MAPTMEN1KMT2A
SCHEMBL20109258 0.82 KMT2A (0.44) MMP8ALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180118770-A1 N-Heterocyclic Phosphines THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS 2018-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180118770-A1 N-Heterocyclic Phosphines NANP, PPIP5K2, PHPT1 MMP8 4444/4885ALDH1A1 4621/4885TP53 1611/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.